Bicara Therapeutics signs Boston sublease with nine months free—but adds a sizable occupancy commitment

The filing adds a concrete facility commitment, not a financing or operating update. Bicara is taking approximately 35,090 rentable square feet at Boston’s St. James Building, with the term ending no later than September 30, 2028; the agreement still requires landlord and overlandlord consent before becoming effective.

The near-term economics are favorable, but the later commitment is meaningful. Bicara receives nine months with no base rent, while the space is delivered furnished and in existing condition. 〔0〕 The company will nevertheless owe roughly $1.16 million in base rent over the maximum 11-month period after rent begins, before electricity, internet, outside-hours HVAC and other additional costs.

The main trade-off is flexibility versus capacity. The arrangement gives Bicara a furnished office and laboratory-adjacent corporate footprint without an immediate rent burden, but it also creates a fixed occupancy obligation for a clinical-stage biotechnology company. The lease is gross for operating expenses, taxes and ordinary utilities, limiting some cost uncertainty, while the premises remain “as-is” and Bicara must fund furnishing, data connections and permitted build-out.

Relative to expectations, this is best read as mixed rather than a clean positive or negative. No published financial or lease benchmark is provided here, so there is no substantiated beat-or-miss comparison. The rent-free period and included furniture reduce initial cash cost; the $105,279 monthly rent, security deposit and fit-out obligations add a material future cash commitment. The immediate gating item is execution of the required third-party consent, without which the sublease does not take effect.